hoe 33342 has been researched along with Sarcoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Busch, TM; Emanuele, MJ; Evans, SM; Fraker, DL; Glatstein, E; Gleason, K; Hahn, SM; Jenkins, K; Koch, CJ; Putt, M; Shin, DB; Wileyto, EP; Zhang, P | 1 |
| Rojiani, AM; Siemann, DW | 1 |
| Ohnemus, B; Severin, E | 1 |
3 other study(ies) available for hoe 33342 and Sarcoma
| Article | Year |
|---|---|
Hypoxia and Photofrin uptake in the intraperitoneal carcinomatosis and sarcomatosis of photodynamic therapy patients.
Topics: Appendiceal Neoplasms; Benzimidazoles; Binding, Competitive; Carbocyanines; Colonic Neoplasms; Dihematoporphyrin Ether; Etanidazole; Female; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Humans; Hydrocarbons, Fluorinated; In Vitro Techniques; Intestine, Small; Male; Microscopy, Fluorescence; Ovarian Neoplasms; Oxygen; Photochemotherapy; Sarcoma | 2004 |
The vascular disrupting agent ZD6126 shows increased antitumor efficacy and enhanced radiation response in large, advanced tumors.
Topics: Angiogenesis Inhibitors; Animals; Benzimidazoles; Drug Screening Assays, Antitumor; Fluorescent Dyes; Humans; Mice; Mice, Inbred C3H; Mice, Nude; Necrosis; Neoplasms; Neovascularization, Pathologic; Organophosphorus Compounds; Sarcoma; Transplantation, Heterologous | 2005 |
UV dose-dependent increase in the Hoechst fluorescence intensity of both normal and BrdU-DNA.
Topics: Animals; Benzimidazoles; Bisbenzimidazole; Bromodeoxyuridine; DNA; DNA, Neoplasm; Dose-Response Relationship, Radiation; Fluorescent Dyes; Fluorometry; Mice; Microscopy, Fluorescence; Sarcoma; T-Lymphocytes; Thymidine; Ultraviolet Rays | 1982 |